Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS Genet. 2010 Dec 23;6(12):e1001257. doi: 10.1371/journal.pgen.1001257.

Cancer and neurodegeneration: between the devil and the deep blue sea.

Author information

1
Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. h.plun-favreau@ion.ucl.ac.uk

Abstract

Cancer and neurodegeneration are often thought of as disease mechanisms at opposite ends of a spectrum; one due to enhanced resistance to cell death and the other due to premature cell death. There is now accumulating evidence to link these two disparate processes. An increasing number of genetic studies add weight to epidemiological evidence suggesting that sufferers of a neurodegenerative disorder have a reduced incidence for most cancers, but an increased risk for other cancers. Many of the genes associated with either cancer and/or neurodegeneration play a central role in cell cycle control, DNA repair, and kinase signalling. However, the links between these two families of diseases remain to be proven. In this review, we discuss recent and sometimes as yet incomplete genetic discoveries that highlight the overlap of molecular pathways implicated in cancer and neurodegeneration.

PMID:
21203498
PMCID:
PMC3009676
DOI:
10.1371/journal.pgen.1001257
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center